Metabolic scientist Ben Bikman shares a short post tagged around GLP-1 drugs, metabolism and low carb diets. Little detail beyond the tags.
Recap by typeshit. Post by @benbikmanphd on Instagram.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
A short TikTok makes the case against plans and insurers dropping coverage of GLP-1 drugs prescribed for weight loss.
Jessie Inchauspé describes GLP-1 as a hormone released after eating and claims certain habits could boost it. These claims are hers and unproven here.
Loading…